retatrutide clinical trial south korea Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Retatrutide's mechanisms of action. |

Novo Nordisk filed its New Drug Application with the FDA on 18 December 2025, based on data from the REDEFINE 1 trial

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to map 14 pathways, 49 peptides, and 150+ genetic insights

The fiber timing rule Do not take fiber supplements within 1-2 hours of your GLP-1 medication

More than one in eight patients on retatrutide were completely free of knee pain by the end of the trial an outcome with meaningful implications for patients whose joint pain is driven or worsened by excess weight

Until the FDA reviews the full evidence and approves it, retatrutide wont be legally available as a prescription drug

If you are experiencing adverse effects from Mounjaro or have concerns about the medication remaining in your system, the most appropriate course of action is to discontinue further injections under medical supervision